105 related articles for article (PubMed ID: 5854414)
1. The treatment of experimental mouse hemoblastosis. 3. Chemotherapy of the LaH VUFB leukemia with some 4-amino analogues of folic acid.
Soucek J; Sochman J; Motycka K; Novotná O; Slavík K
Neoplasma; 1965; 12(4):425-33. PubMed ID: 5854414
[No Abstract] [Full Text] [Related]
2. Studies on the effect of antifolics in mouse leukemia.
Motycka K
Natl Cancer Inst Monogr; 1971 Dec; 34():167-77. PubMed ID: 4110901
[No Abstract] [Full Text] [Related]
3. Treatment of experimental mouse hemoblastosis. VII. Time course of change in the frequency of mitoses of leukaemic leukocytes (L 14 AKR and LaH VUFB) after administration of methotrexate.
Motycka K; Stránská E; Andrysek O; Coufalová H; Jehlicková M
Neoplasma; 1970; 17(2):137-42. PubMed ID: 5425391
[No Abstract] [Full Text] [Related]
4. [The biological and therapeutic value of 4-aminopteroylaminoadipic acid].
Trufanov AV; Dzhelieva ZN
Vopr Med Khim; 1972; 18(4):418-21. PubMed ID: 4196602
[No Abstract] [Full Text] [Related]
5. [New route of regulating folic acid metabolism in experimental chemotherapy of leukoses and malignant neoplasms].
Bukin IuV; Sergeev AV; Raushenbakh MO
Vestn Akad Med Nauk SSSR; 1971; 26(3):49-55. PubMed ID: 4326180
[No Abstract] [Full Text] [Related]
6. [Comparative study of the characteristics and activity of tetrahydrofolate dehydrogenases of rat liver and spleen in leukemias of viral etiology].
Sergeev AV
Vopr Med Khim; 1968; 14(6):606-11. PubMed ID: 5733701
[No Abstract] [Full Text] [Related]
7. The association of increased dihydrofolate reductase with amethopterin resistance in mouse leukemia.
FRIEDKIN M; CRAWFORD E; HUMPHREYS SR; GOLDIN A
Cancer Res; 1962 Jun; 22():600-6. PubMed ID: 13895219
[No Abstract] [Full Text] [Related]
8. The treatment of experimental mouse hemoblastosis. VI.
Pristoupilová K; Soucek J; Motycka K; Slavík K
Neoplasma; 1968; 15(1):77-87. PubMed ID: 5689889
[No Abstract] [Full Text] [Related]
9. THE TREATMENT OF EXPERIMENTAL MOUSE HEMOBLASTOSIS. II. THE EFFECT OF LONG-TERM ADMINISTRATION OF SOME FOLIC ACID ANTAGONISTS ON MICE OF THE AKR STRAIN.
MOTYCKA K; SOUCEK J; SLAVIK K
Neoplasma; 1964; 11():399-408. PubMed ID: 14200028
[No Abstract] [Full Text] [Related]
10. Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cells.
FISCHER GA
Biochem Pharmacol; 1961 Jul; 7():75-7. PubMed ID: 13699838
[No Abstract] [Full Text] [Related]
11. Nonclassical 2,4-diamino-8-deazafolate analogues as inhibitors of dihydrofolate reductases from rat liver, Pneumocystis carinii, and Toxoplasma gondii.
Gangjee A; Zhu Y; Queener SF; Francom P; Broom AD
J Med Chem; 1996 Apr; 39(9):1836-45. PubMed ID: 8627607
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model.
Graffner-Nordberg M; Fyfe M; Brattsand R; Mellgård B; Hallberg A
J Med Chem; 2003 Jul; 46(16):3455-62. PubMed ID: 12877583
[TBL] [Abstract][Full Text] [Related]
13. Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
Baker BR; Lourens GJ; Meyer RB; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):67-73. PubMed ID: 5763043
[No Abstract] [Full Text] [Related]
14. Conference on obstacles to the control of acute leukemia. Limitations on the therapeutic effectiveness of the folic acid antagonists.
Werkheiser WC
Cancer Res; 1965 Oct; 25(9):1608-13. PubMed ID: 5323970
[No Abstract] [Full Text] [Related]
15. Biochemical pharmacology of lipophilic diaminopyrimidine antifolates in mouse and human cells in vitro.
Greco WR; Hakala MT
Mol Pharmacol; 1980 Nov; 18(3):521-8. PubMed ID: 6970329
[No Abstract] [Full Text] [Related]
16. [Lysosomal hydrolase activity during development of experimental leukemia].
Drozhennikov VA; Perevezentseva OS
Biull Eksp Biol Med; 1980 Jun; 89(6):715-6. PubMed ID: 7397362
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of formate-C-14 in normal and leukemic mice during extended treatment with amethopterin and 3',5'-dichloramethopterin.
SCHRECKER AW; MEAD JA; GOLDIN A
Cancer Res; 1962 Jan; 22():15-20. PubMed ID: 13909245
[No Abstract] [Full Text] [Related]
18. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
[TBL] [Abstract][Full Text] [Related]
19. Empirical vs. rational approaches in cancer chemotherapy.
Friedkin M; Crawford EJ; Plante LT
Ann N Y Acad Sci; 1971 Nov; 186():209-13. PubMed ID: 5002298
[No Abstract] [Full Text] [Related]
20. Effects of A-methopterin on nucleic acid synthesis in leukemia spleen breis.
BALIS ME; DANCIS J
Cancer Res; 1955 Oct; 15(9):603-8. PubMed ID: 13261082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
